Pure Global AI
NCT06324669Recruiting

The Effect of a Ketone Drink on Blood Glucose Levels in People With Type 2 Diabetes

Investigating the Blood Glucose Lowering Effect of Exogenous Ketone Ingestion in People With Type 2 Diabetes
University of ExeterClinicalTrials.govdietary supplement
Verified
Study focus
Disease/Condition
Type 2 Diabetes
Drug/Device/Intervention
Ketone supplement
Study type
Interventional
Intervention type
dietary supplement
Sponsor & location
Primary sponsor
University of Exeter
Location
Exeter, United Kingdom
Timeline & enrollment
Phase
N/A
Start date
Mar 16, 2024
End date
Jan 31, 2026
Enrollment
15 participants
Primary outcome

Rate of endogenous glucose production

Summary

Ketones are naturally produced by our body and can affect our blood sugar levels. Ketones
 could be important in the treatment of type 2 diabetes (T2D). The purpose of this research is
 to determine if a ketone drink can lower blood sugar in people with T2D following a meal.
 This research will provide new knowledge about the regulation of blood sugar. This may also
 inform if ketone drinks could be used as a treatment for T2D.

ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus with multiple complications
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06324669
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06324669 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Exeter and is currently Recruiting. The study focuses on Type 2 Diabetes. Target enrollment is 15 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.